 |
|
|
| |
Week 144 Renal Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF (STB)
from Two Phase 3 Randomized Controlled Trials
|
| |
| |
Reported by Jules Levin
20th International AIDS Conference, July 20-25, 2014, Melbourne
C Cohen1, F Post2, J Winston3, B Hendry2, B Gazzard4, P Girard5, G Faetkenheur6, A Antinori7, M Fisher8, C Tran-Muchowski9, H Liu9, D Piontkowsky9, M Rhee9, J Szwarcberg9
1Community Research Initiative, Boston, MA, USA; 2KingÕs college London School of Medicine, UK; 3Mount Sinai School of Medicine, New York, NY, USA; 4Chelsea and Westminister Hospital, London, UK; 5 5H™pital Saint-Antoine, Paris, France Universitˇ Pierre et Marie Curie, Paris, France; 6University Hospital of Cologne, Cologne, Germany; 7Istituto Nazionale per le Malattie Infettive, Rome Italy; 8Brighton and Sussex Medical School, Brighton, UK; 9Gilead Sciences, Foster City, CA, USA
|
| |
|
|
|
|
|
